Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DTCFF - Defence Therapeutics and Orano to develop next gen targeted radio-immunotherapy for cancer

DTCFF - Defence Therapeutics and Orano to develop next gen targeted radio-immunotherapy for cancer

Defence Therapeutics Inc Cl A

2023-03-14 04:47:48 ET

  • Defence Therapeutics ( OTCPK:DTCFF ) to collaborate with Orano Support SAS on behalf of Orano SA to develop the next generation of radio-immunoconjugates for radio-immunotherapy using Defence's intracellular targeting technology.
  • Defence will develop the first radio-immuno-conjugates therapy based on Auger electron emitter by combining Defence's intracellular targeting expertise and radiochemistry expertise provided by Orano.
  • The best results should lead to an optimize product from which a GLP tox studies will then be planned accordingly.

For further details see:

Defence Therapeutics and Orano to develop next gen targeted radio-immunotherapy for cancer
Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...